A recent clinical trial has demonstrated that a structured three-year exercise program, initiated soon after the completion of adjuvant chemotherapy for colon cancer, can significantly improve disease-free survival in patients. Conducted under the CHALLENGE trial and funded by the Canadian Cancer Society and other supporters, the study offers compelling evidence that physical activity may play a critical role in preventing cancer recurrence.
The randomized trial targeted individuals who had completed chemotherapy for stage II or III colon cancer. Participants engaged in a supervised and progressively intensive physical activity regimen over the course of three years, which was designed to be realistic and reproducible in a clinical setting. The goal was to determine whether exercise could extend the period patients remained free of cancer recurrence.
Results from the study revealed that those in the exercise cohort experienced a statistically significant increase in disease-free survival compared to those who did not participate in the exercise program. While final data on overall survival are still emerging, preliminary findings suggest a trend toward improved outcomes in this area as well.
Experts believe that regular physical activity may reduce inflammation, improve immune function, and positively affect metabolic factors—all of which can influence cancer prognosis. These findings not only reinforce the value of exercise as part of cancer survivorship plans but may also prompt healthcare providers to include structured physical activity programs as a standard component of post-chemotherapy care for colon cancer patients.
The trial, registered under ClinicalTrials.gov number NCT00819208, highlights a promising direction in supportive oncology care, emphasizing lifestyle interventions as powerful tools in improving long-term outcomes for cancer survivors.
Source: https:// – Courtesy of the original publisher.
